SPY345.78+1.17 0.34%
DIA283.34-0.31 -0.11%
IXIC11,548.28+42.28 0.37%

JP Morgan Maintains Overweight on Bristol-Myers Squibb, Raises Price Target to $78

JP Morgan maintains Bristol-Myers Squibb (NYSE:BMY) with a Overweight and raises the price target from $74 to $78.

· 10/16/2020 12:24
JP Morgan maintains Bristol-Myers Squibb (NYSE:BMY) with a Overweight and raises the price target from $74 to $78.